NR3C1 and cancer: Glucocorticoids also inhibit cell proliferation and cancer cell growth induced by oestradiol and progesterone [36–38] and glucocorticoid receptor (GR) positivity of ER + PR+ and ER + PR - subtypes is associated with longer relapse-free survival [39].